ADVFN US – Market Content Editor

Aebi Schmidt Holding AG (NASDAQ:AEBI) stock fell 15.4% after the specialty vehicle manufacturer reported a second-quarter net loss following its recent merger with The Shyft Group. The company, which completed the merger on July 1, posted second-quarter sales of $277.7 million, up 4.2% from $266.5 million in the same period last year. Despite higher sales,…

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) stock fell 6% following Sarepta Therapeutics’ (NASDAQ:SRPT) sale of over 9.2 million Arrowhead shares in a privately negotiated block trade. Sarepta expects to receive at least $174 million in gross proceeds from the transaction. In addition, approximately 2.66 million Arrowhead shares will be transferred to satisfy $50 million of a previously…

Tilray Brands Inc (NASDAQ:TLRY) stock fell 12.8% following the company’s announcement that it has requested an extension to regain compliance with Nasdaq’s minimum share price rules. The cannabis and consumer goods company is considering several options, including a potential stockholder-approved reverse stock split, to maintain its Nasdaq listing. Tilray’s shares have been trading below the…

Schrödinger Inc (NASDAQ:SDGR) shares dropped 13.7% following the company’s announcement that it is discontinuing development of its CDC7 inhibitor, SGR-2921, which was being evaluated in a Phase 1 study for leukemia patients. The decision comes after two treatment-related deaths occurred in the Phase 1 dose-escalation trial involving patients with relapsed/refractory acute myeloid leukemia (AML) or…

Ulta Beauty (NASDAQ:ULTA) shares dropped 2% Thursday morning following the announcement that the company will not renew its shop-in-shop partnership with Target (NYSE:TGT) when the current agreement expires in August 2026. The partnership, which began in 2021, will continue until its expiration, with Ulta Beauty at Target locations operating in-store and online at Target.com. Customers…

Beam Therapeutics Inc. (NASDAQ:BEAM) shares jumped 12% following the announcement that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to BEAM-101, the company’s investigational cell therapy for sickle cell disease. The RMAT designation, which comes after an earlier orphan drug designation, provides Beam with opportunities for closer FDA…

Lazydays Holdings, Inc. (NASDAQ:GORV) posted a second-quarter net loss of $6.67 per share on revenue of $131.3 million Thursday, showing progress in its turnaround efforts despite significantly lower sales volumes. Shares edged up 0.95% in after-hours trading following the results. Revenue declined 44.3% year-over-year from $235.6 million in Q2 2024, reflecting the company’s streamlined footprint…

The Oncology Institute, Inc. (NASDAQ:TOI) saw its shares fall 7.07% in pre-market trading Thursday after reporting second-quarter earnings that fell short of analyst expectations, despite posting revenue above forecasts. The value-based community oncology provider reported a loss of $0.15 per share for Q2, missing estimates of a $0.09 loss by $0.06. Revenue, however, reached $119.8…

Samsonite (USOTC:SMSEY) reported a 5% decline in second-quarter sales, slightly outperforming Morgan Stanley’s estimates, while adjusted EBITDA came in at $141 million, in line with expectations. The luggage maker’s EBITDA margin reached 16.3%, below the forecasted 16.8%, mainly due to lower gross profit margins—likely driven by increased promotional activity—and higher distribution costs associated with new…

McGraw Hill, Inc. (NYSE:MH) surpassed revenue expectations in its first-quarter fiscal 2026 results on Thursday, with total revenue reaching $535.7 million, up 2.4% year-over-year, driven by strong performance in digital and recurring revenue. Shares slipped 0.21% in after-hours trading following the announcement. The education solutions provider reported breakeven earnings per share for the quarter ended…